Receptors for myelin inhibitors: Structures and therapeutic opportunities.
about
Sialidase enhances recovery from spinal cord contusion injuryEnhancing CNS repair in neurological disease: challenges arising from neurodegeneration and rewiring of the networkThe role of the Rho/ROCK signaling pathway in inhibiting axonal regeneration in the central nervous systemAxon regeneration impediment: the role of paired immunoglobulin-like receptor BSialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regenerationWallerian degeneration: the innate-immune response to traumatic nerve injuryBrain gangliosides in axon-myelin stability and axon regeneration.Effects of Bu Shen Yi sui capsule on NogoA/NgR and its signaling pathways RhoA/ROCK in mice with experimental autoimmune encephalomyelitisMethylprednisolone inhibits Nogo-A protein expression after acute spinal cord injury.Myelin-associated proteins block the migration of olfactory ensheathing cells: an in vitro study using single-cell tracking and traction force microscopy.The potential of LINGO-1 as a therapeutic target for essential tremor.Myelin-associated glycoprotein protects neurons from excitotoxicity.Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPα (signal regulatory protein-α) on phagocytes.High affinity sialoside ligands of myelin associated glycoprotein.The novel protein MANI modulates neurogenesis and neurite-cone growth.Hippocampal expression of myelin-associated inhibitors is induced with age-related cognitive decline and correlates with deficits of spatial learning and memory.Concepts and methods for the study of axonal regeneration in the CNSComplement receptor-3 negatively regulates the phagocytosis of degenerated myelin through tyrosine kinase Syk and cofilin.Herpes simplex virus infects most cell types in vitro: clues to its successGlycogen synthase kinase 3 beta (GSK3β) at the tip of neuronal development and regeneration.Lipid rafts in neurodegeneration and neuroprotection.Scar-modulating treatments for central nervous system injury.Drug discovery for remyelination and treatment of MS.Inhibition of repulsive guidance molecule, RGMa, increases afferent synapse formation with auditory hair cellsReceptor tyrosine kinases: molecular switches regulating CNS axon regeneration.Overcoming amino-Nogo-induced inhibition of cell spreading and neurite outgrowth by 12-O-tetradecanoylphorbol-13-acetate-type tumor promoters.TAT-NEP1-40 as a novel therapeutic candidate for axonal regeneration and functional recovery after stroke.Spatio-temporal expression of paired immunoglobulin-like receptor-B in the adult mouse brain after focal cerebral ischaemia.Inhibition of neurite outgrowth using commercial myelin associated glycoprotein-Fc in neuro-2a cells
P2860
Q24623448-43D46487-2236-42B8-A0D4-A6A0D0381495Q24630696-81EA7C73-6C91-40E4-9ED9-2B4054CBADBFQ26775044-63B0AF61-EAF9-4F36-890E-6ECC09A5A513Q26781076-B63B3E6B-676A-4B76-B1DD-4B187F998A55Q26995291-6AB73CD2-AB88-430D-8AA1-B47D2D8252E4Q26999323-DF625631-8461-4B4E-98CC-2281A0D94A2BQ33798789-793F1394-75E2-4D67-9FBA-8DE4BFE7A011Q33862545-38CA8F74-724E-48CB-9C54-627BE2A87D77Q34095543-4E2AB23D-3D00-4EF2-9C2C-D400E482E19AQ34243425-37D69960-A172-4F25-B867-DAFD42B4D6CEQ34471202-25715777-7C3B-4062-8FAB-0597902C519CQ34686899-DC421FBA-EE05-4A9A-92EE-4002EB06075EQ34743665-D12921B4-8F41-4FB2-8601-A129482A2001Q35165362-DEB09710-D4E2-4525-83E1-996E44FF70E4Q35216151-00FAABB5-E2FD-41E0-818B-6C9A42EEFB23Q35926397-3DF2CEED-8F52-45AF-A568-F24DA9B25A4BQ36070952-10C7464E-B9DF-4D46-9674-19A64724A0DFQ36162628-0DCADDF1-6543-4EFE-82D4-FBCD5D10C0DEQ37949631-C0E5D9F3-1B1F-425B-A873-636675B58561Q38155462-DCD4F921-3A9F-474A-983B-DB6F963EB49AQ38173298-9105090A-89F1-48F3-B0D1-B4BF55417B0BQ38222632-A18EA878-7AF4-45E2-A3E5-00C88482984AQ39375830-5C0E567A-E63E-4E38-98BA-23EF187199C1Q41213836-6BFF1A93-DABB-4BF7-9ECB-773C1C0119ACQ41819306-92CF1086-3023-4C18-BE66-00D7CCC1CFD0Q42204289-E1A96EDD-974D-41C3-B9A2-4C89C9ECDE10Q43847264-ED18E632-2B3D-4849-BD60-0DDE7FBD4D43Q44965561-341572AD-7556-42FE-A986-B3565BC22F9BQ58702634-E24448D3-C16B-439A-8D2B-1B97E6B72133
P2860
Receptors for myelin inhibitors: Structures and therapeutic opportunities.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Receptors for myelin inhibitors: Structures and therapeutic opportunities.
@en
Receptors for myelin inhibitors: Structures and therapeutic opportunities.
@nl
type
label
Receptors for myelin inhibitors: Structures and therapeutic opportunities.
@en
Receptors for myelin inhibitors: Structures and therapeutic opportunities.
@nl
prefLabel
Receptors for myelin inhibitors: Structures and therapeutic opportunities.
@en
Receptors for myelin inhibitors: Structures and therapeutic opportunities.
@nl
P2093
P1476
Receptors for myelin inhibitors: Structures and therapeutic opportunities.
@en
P2093
Frank S Walsh
Kangwen Deng
Zixuan Cao
P356
10.1016/J.MCN.2009.07.008
P577
2009-07-18T00:00:00Z